Page last updated: 2024-09-05

lapatinib and lonafarnib

lapatinib has been researched along with lonafarnib in 1 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
(lonafarnib)
Trials
(lonafarnib)
Recent Studies (post-2010) (lonafarnib)
1,9193051,4422243490

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)lonafarnib (IC50)
Chain A, Protein farnesyltransferase alpha subunitRattus norvegicus (Norway rat)0.0019
Chain B, Protein farnesyltransferase beta subunitRattus norvegicus (Norway rat)0.0019
GTPase HRasHomo sapiens (human)0.07
ATP-dependent translocase ABCB1Homo sapiens (human)2.7
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaBos taurus (cattle)0.0081
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)0.1498
Protein farnesyltransferase subunit betaBos taurus (cattle)0.0081
Protein farnesyltransferase subunit betaHomo sapiens (human)0.1498
Protein farnesyltransferase subunit betaRattus norvegicus (Norway rat)0.0019
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaRattus norvegicus (Norway rat)0.0019

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dowlati, A; Halmos, B; Kern, JA; Kluge, A; Nethery, D1

Other Studies

1 other study(ies) available for lapatinib and lonafarnib

ArticleYear
SCH66336, inhibitor of protein farnesylation, blocks signal transducer and activators of transcription 3 signaling in lung cancer and interacts with a small molecule inhibitor of epidermal growth factor receptor/human epidermal growth factor receptor 2.
    Anti-cancer drugs, 2008, Volume: 19, Issue:1

    Topics: Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Colorimetry; Drug Synergism; Flow Cytometry; Humans; Indicators and Reagents; Lapatinib; Mutation; Oncogene Protein v-akt; Piperidines; Prenylation; Pyridines; Quinazolines; Receptor, ErbB-2; Signal Transduction; STAT3 Transcription Factor

2008